Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistence of spike-specific immune responses in BNT162b2-vaccinated donors and generation of rapid ex-vivo T cells expansion protocol for adoptive immunotherapy: A pilot study.
Mestiri S, Merhi M, Inchakalody VP, Taib N, Smatti MK, Ahmad F, Raza A, Ali FH, Hydrose S, Fernandes Q, Ansari AW, Sahir F, Al-Zaidan L, Jalis M, Ghoul M, Allahverdi N, Al Homsi MU, Uddin S, Jeremijenko AM, Nimir M, Abu-Raddad LJ, Abid FB, Zaqout A, Alfheid SR, Saqr HMH, Omrani AS, Hssain AA, Al Maslamani M, Yassine HM, Dermime S. Mestiri S, et al. Among authors: hssain aa. Front Immunol. 2023 Feb 2;14:1061255. doi: 10.3389/fimmu.2023.1061255. eCollection 2023. Front Immunol. 2023. PMID: 36817441 Free PMC article.
A CRISPR-based approach using dead Cas9-sgRNA to detect SARS-CoV-2.
Aouida M, Saifaldeen M, Al-Ansari DE, Taleb S, Hssain AA, Ramotar D. Aouida M, et al. Among authors: hssain aa. Front Mol Biosci. 2023 Jun 14;10:1201347. doi: 10.3389/fmolb.2023.1201347. eCollection 2023. Front Mol Biosci. 2023. PMID: 37388245 Free PMC article.
EVALUATION OF HYDROCORTISONE, VITAMIN C, AND THIAMINE FOR THE TREATMENT OF SEPTIC SHOCK: A RANDOMIZED CONTROLLED TRIAL (THE HYVITS TRIAL).
Mohamed A, Abdelaty M, Saad MO, Shible A, Mitwally H, Akkari AR, Elbuzidi A, Bintaher A, Hashim A, Abdelrahim M, Afzal M, El-Enany R, El-Hamid M, Bakdach D, Karic E, Shehatta A, Ibrahim AS, Lance M, Hssain AA, Hassan I. Mohamed A, et al. Among authors: hssain aa. Shock. 2023 May 1;59(5):697-701. doi: 10.1097/SHK.0000000000002110. Epub 2023 Mar 8. Shock. 2023. PMID: 36870070 Free PMC article. Clinical Trial.
A randomised clinical trial of awake prone positioning in COVID-19 suspects with acute hypoxemic respiratory failure.
Harris TRE, Bhutta ZA, Qureshi I, Kharma N, Raza T, Hssain AA, Pathare AS, D'Silva A, Khatib MY, Mohamedali MGH, Macineira IMG, Garcia Hernandez VR, Garcia JR, Thomas SH, Pathan SA. Harris TRE, et al. Among authors: hssain aa. Contemp Clin Trials Commun. 2024 Apr 13;39:101295. doi: 10.1016/j.conctc.2024.101295. eCollection 2024 Jun. Contemp Clin Trials Commun. 2024. PMID: 38689829 Free PMC article.
Correction: The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. Buetti N, et al. Intensive Care Med. 2024 Apr 8. doi: 10.1007/s00134-024-07415-6. Online ahead of print. Intensive Care Med. 2024. PMID: 38587556 No abstract available.
SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
Zedan HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, Nicolai E, Pieri M, Bernardini S, Hssain AA, Taleb S, Qotba H, Issa K, Abu Raddad LJ, Althani AA, Nasrallah GK, Yassine HM. Zedan HT, et al. Among authors: hssain aa. J Med Virol. 2024 Mar;96(3):e29527. doi: 10.1002/jmv.29527. J Med Virol. 2024. PMID: 38511514
The role of centre and country factors on process and outcome indicators in critically ill patients with hospital-acquired bloodstream infections.
Buetti N, Tabah A, Setti N, Ruckly S, Barbier F, Akova M, Aslan AT, Leone M, Bassetti M, Morris AC, Arvaniti K, Paiva JA, Ferrer R, Qiu H, Montrucchio G, Cortegiani A, Kayaaslan B, De Bus L, De Waele JJ, Timsit JF; EUROBACT-2 Study Group, the European Society of Intensive Care Medicine (ESICM), the European Society of Clinical Microbiology, the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP), and the OUTCOMEREA Network. Buetti N, et al. Intensive Care Med. 2024 Mar 18. doi: 10.1007/s00134-024-07348-0. Online ahead of print. Intensive Care Med. 2024. PMID: 38498170
57 results